Analysts expect Sangamo Therapeutics to report an earnings per share (EPS) of $-0.03.
Anticipation surrounds Sangamo Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
Last quarter the company missed EPS by $0.03, which was followed by a 13.46% drop in the share price the next day.
Here's a look at Sangamo Therapeutics's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
-0.15
-0.21
-0.26
-0.32
EPS Actual
-0.18
-0.27
-0.34
-0.59
Price Change %
-13.0%
7.000000000000001%
-1.0%
-22.0%
Sangamo Therapeutics Share Price Analysis
Shares of Sangamo Therapeutics were trading at $2.87 as of November 08. Over the last 52-week period, shares are up 763.58%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Views on Sangamo Therapeutics
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Sangamo Therapeutics.
The consensus rating for Sangamo Therapeutics is Buy, based on 4 analyst ratings. With an average one-year ...
